NO20003918D0 - Histamin H3 reseptor ligander - Google Patents
Histamin H3 reseptor liganderInfo
- Publication number
- NO20003918D0 NO20003918D0 NO20003918A NO20003918A NO20003918D0 NO 20003918 D0 NO20003918 D0 NO 20003918D0 NO 20003918 A NO20003918 A NO 20003918A NO 20003918 A NO20003918 A NO 20003918A NO 20003918 D0 NO20003918 D0 NO 20003918D0
- Authority
- NO
- Norway
- Prior art keywords
- replaced
- hydrocarbyl
- histamine
- halogen
- receptor ligands
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/24—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by sulfur atoms to which a second hetero atom is attached
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrane Compounds (AREA)
- Pyrrole Compounds (AREA)
- Quinoline Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9803536.3A GB9803536D0 (en) | 1998-02-19 | 1998-02-19 | Histamine H,receptor ligands |
PCT/GB1999/000464 WO1999042458A1 (en) | 1998-02-19 | 1999-02-15 | Histamine h3 receptor ligands |
Publications (3)
Publication Number | Publication Date |
---|---|
NO20003918D0 true NO20003918D0 (no) | 2000-08-02 |
NO20003918L NO20003918L (no) | 2000-10-03 |
NO323966B1 NO323966B1 (no) | 2007-07-23 |
Family
ID=10827270
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20003918A NO323966B1 (no) | 1998-02-19 | 2000-08-02 | Histamin H<N>3</N> reseptor-ligander, farmasooytisk preparat inneholdende samme og anvendelse av samme for fremstilling av medikament |
Country Status (16)
Country | Link |
---|---|
US (1) | US6878736B1 (no) |
EP (1) | EP1056733B1 (no) |
JP (1) | JP2002504483A (no) |
CN (1) | CN1178927C (no) |
AT (1) | ATE257473T1 (no) |
AU (1) | AU747804B2 (no) |
BR (1) | BR9908074A (no) |
CA (1) | CA2318836A1 (no) |
DE (1) | DE69914062T2 (no) |
ES (1) | ES2213353T3 (no) |
GB (1) | GB9803536D0 (no) |
NO (1) | NO323966B1 (no) |
NZ (1) | NZ506720A (no) |
RU (1) | RU2214406C2 (no) |
WO (1) | WO1999042458A1 (no) |
ZA (1) | ZA991356B (no) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6355655B1 (en) | 1998-07-31 | 2002-03-12 | Eli Lilly And Company | Heterocyclic sulphonamide derivatives |
US6610721B2 (en) | 2000-03-17 | 2003-08-26 | Novo Nordisk A/S | Imidazo heterocyclic compounds |
WO2001068651A1 (en) * | 2000-03-17 | 2001-09-20 | Novo Nordisk A/S | Condensed imidazoles as histamine h3 receptor ligands |
US20030114420A1 (en) * | 2000-06-28 | 2003-06-19 | Salvati Mark E. | Fused cyclic modulators of nuclear hormone receptor function |
US6638967B2 (en) | 2000-08-08 | 2003-10-28 | Ortho-Mcneil Phamraceutical, Inc. | Thiophene of furan pyrrolidine compounds |
AU2001281121B2 (en) | 2000-08-08 | 2007-08-23 | Ortho-Mcneil Pharmaceutical, Inc. | Non-imidazole aryloxypiperidines as H3 receptor ligands |
PT1313721E (pt) | 2000-08-08 | 2006-06-30 | Ortho Mcneil Pharm Inc | Ariloxialquilaminas nao imidazoles como ligandos de receptor h3 |
JP4653935B2 (ja) * | 2001-03-29 | 2011-03-16 | オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド | ヒスタミンh3受容体のリガンドとして用いるに有用なイミダゾリル誘導体 |
US7208497B2 (en) | 2001-07-02 | 2007-04-24 | Novo Nordisk A/S | Substituted piperazines and diazepanes |
JP2005502623A (ja) | 2001-07-02 | 2005-01-27 | ノボ ノルディスク アクティーゼルスカブ | 置換ピペラジンおよびジアゼパン |
JP4619655B2 (ja) * | 2001-09-14 | 2011-01-26 | ハイ・ポイント・ファーマスーティカルズ、エルエルシー | 新規アミノアゼチジン、−ピロリジンおよび−ピペリジン誘導体 |
US6673829B2 (en) | 2001-09-14 | 2004-01-06 | Novo Nordisk A/S | Aminoazetidine,-pyrrolidine and -piperidine derivatives |
US20030186963A1 (en) | 2001-09-14 | 2003-10-02 | Dorwald Florencio Zaragoza | Substituted piperidines |
US7064135B2 (en) | 2001-10-12 | 2006-06-20 | Novo Nordisk Inc. | Substituted piperidines |
EP1444219A1 (en) | 2001-10-12 | 2004-08-11 | Novo Nordisk A/S | Substituted piperidines and their use for the treatment of diseases related to the histamine h3 receptor |
CN1617865A (zh) | 2001-12-10 | 2005-05-18 | 奥索-麦克尼尔药品公司 | 苯炔 |
US20040002604A1 (en) | 2001-12-10 | 2004-01-01 | Richard Apodaca | Phenylalkynes |
SI1558595T1 (sl) | 2002-10-23 | 2010-03-31 | Janssen Pharmaceutica Nv | Piperazinilni in diazapanilni benzamidi in benztioamidi |
WO2004037257A1 (en) | 2002-10-23 | 2004-05-06 | Janssen Pharmaceutica, N.V. | Phenylpiperidines and phenylpyrrolidines as histamine h3 receptor modulators |
ITTO20030668A1 (it) | 2003-09-02 | 2005-03-03 | Rotta Res Lab S P A O Ra Rottapharm | Derivati dell'adamantano dotati di attivita' neuroprotettiva, antidepressiva e anti-ischemica e procedimento per la loro preparazione. |
US7423176B2 (en) * | 2004-04-13 | 2008-09-09 | Cephalon, Inc. | Bicyclic aromatic sulfinyl derivatives |
WO2005110998A1 (en) | 2004-05-07 | 2005-11-24 | Janssen Pharmaceutica N.V. | Scalable synthesis of imidazole derivatives |
EP1595881A1 (en) * | 2004-05-12 | 2005-11-16 | Pfizer Limited | Tetrahydronaphthyridine derivates useful as histamine H3 receptor ligands |
MY147767A (en) | 2004-06-16 | 2013-01-31 | Janssen Pharmaceutica Nv | Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders |
JP2008545650A (ja) | 2005-05-20 | 2008-12-18 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | スルファミド誘導体の製造方法 |
CA2622760C (en) | 2005-09-16 | 2012-12-04 | Janssen Pharmaceutica N.V. | Cyclopropyl amines as modulators of the histamine h3 receptor |
US8497298B2 (en) | 2005-12-19 | 2013-07-30 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels |
US8691867B2 (en) | 2005-12-19 | 2014-04-08 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction |
US8492431B2 (en) | 2005-12-19 | 2013-07-23 | Janssen Pharmaceutica, N.V. | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of obesity |
US8716231B2 (en) | 2005-12-19 | 2014-05-06 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain |
US8937096B2 (en) | 2005-12-19 | 2015-01-20 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder |
EA200870556A1 (ru) | 2006-05-19 | 2009-06-30 | Янссен Фармацевтика Н.В. | Комбинированная терапия в лечении эпилепсии и родственных расстройств |
ATE538116T1 (de) | 2006-05-29 | 2012-01-15 | High Point Pharmaceuticals Llc | 3-(1,3-benyodioxol-5-yl)-6- (4- cyclopropylpiperazin-1-yl)-pyridazin, dessen salze und solvate und dessen verwendung als histamin-h3-rezeptorantagonist |
EP2014656A3 (en) | 2007-06-11 | 2011-08-24 | High Point Pharmaceuticals, LLC | New heteocyclic h3 antagonists |
WO2009089235A1 (en) * | 2008-01-07 | 2009-07-16 | Janssen Pharmaceutica N.V. | Preparation of sulfamide derivatives |
WO2009089210A1 (en) * | 2008-01-07 | 2009-07-16 | Janssen Pharmaceutica N. V. | Preparation of sulfamide derivatives |
NZ590682A (en) | 2008-06-23 | 2012-09-28 | Janssen Pharmaceutica Nv | Crystalline form of (2S)-(-)-N-(6-chloro-2,3-dihydro-benzo[1,4]dioxin-2-ylmethyl)-sulfamide |
US8815939B2 (en) | 2008-07-22 | 2014-08-26 | Janssen Pharmaceutica Nv | Substituted sulfamide derivatives |
CA2850513A1 (en) * | 2011-09-29 | 2013-04-04 | Janssen Pharmaceutica Nv | Process for the preparation of sulfamide derivatives |
WO2013151982A1 (en) | 2012-04-03 | 2013-10-10 | Arena Pharmaceuticals, Inc. | Methods and compounds useful in treating pruritus, and methods for identifying such compounds |
CN110551077B (zh) * | 2019-09-24 | 2023-01-31 | 新乡市润宇新材料科技有限公司 | 一种光催化分子氧氧化制备n-叔丁基-2-苯并噻唑亚磺酰胺的方法 |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR346879A (fr) * | 1903-10-10 | 1905-02-13 | Alba Thompson Kingsley | Système de serrure à moraillon |
CH342957A (de) * | 1958-06-10 | 1959-12-15 | Ciba Geigy | Verfahren zur Herstellung einer neuen Guanidinverbindung |
CH345893A (de) * | 1958-06-10 | 1960-04-30 | Ciba Geigy | Verfahren zur Herstellung von neuen Guanidinen |
NL251629A (no) * | 1959-05-15 | |||
CH362079A (de) * | 1959-06-10 | 1962-05-31 | Ciba Geigy | Verfahren zur Herstellung neuer Guanidine |
CH390925A (de) * | 1960-05-04 | 1965-04-30 | Ciba Geigy | Verfahren zur Herstellung neuer Diazaverbindungen |
GB952194A (en) * | 1960-12-23 | 1964-03-11 | Smith Kline French Lab | New guanidine derivatives and processes for preparing the same |
FR1352161A (fr) * | 1962-11-19 | 1964-02-14 | Farmaceutici Italia | Procédé pour la préparation d'un nouveau composé, la n-(2'-guanidinoéthyl)-2-méthylpipéridine |
US3317545A (en) * | 1963-08-21 | 1967-05-02 | Hoffmann La Roche | [2-(2, 6-dimethylpiperidino)ethyl]guanidines and intermediates |
GB1185080A (en) * | 1967-12-07 | 1970-03-18 | Beecham Group Ltd | Pyrrolidines |
FR2313918A1 (fr) * | 1975-06-09 | 1977-01-07 | Choay Sa | Methoxy-2 benzenesulfonamides n-substitues, procede pour les preparer et medicaments les contenant |
NZ193654A (en) * | 1979-05-16 | 1984-08-24 | Wuelfing Johann A | Naphthalene sulphonamido-alkyl-piperidines,pyrrolidines or piperazines and pharmaceutical compositions |
DE3065026D1 (en) * | 1979-05-23 | 1983-11-03 | Beecham Wuelfing Gmbh & Co Kg | Phenylsulphonamide derivatives, a process for their preparation and their use as medicines |
DE3579000D1 (de) | 1985-04-02 | 1990-09-06 | Heumann Pharma Gmbh & Co | Imidazolylalkylguanidinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel. |
US5274097A (en) * | 1988-04-19 | 1993-12-28 | Bayer Aktiengesellschaft | 1,3-disubstituted pyrrolidines |
DE3922232A1 (de) | 1989-07-06 | 1991-01-17 | Basf Ag | Fungizide guanidine |
CA2080128A1 (en) | 1991-02-13 | 1992-08-14 | Akiro Kajihara | Substituted sulfonamide derivative and a pharmaceutical composition comprising the same |
CA2104946A1 (en) * | 1991-02-27 | 1992-08-28 | Hendrik Timmerman | Imidazole-derivatives having agonistic or antagonistic activity on the histamine h3-receptor |
FR2686084B1 (fr) | 1992-01-10 | 1995-12-22 | Bioprojet Soc Civ | Nouveaux derives de l'imidazole, leur preparation et leurs applications therapeutiques. |
FR2694003A1 (fr) * | 1992-07-21 | 1994-01-28 | Beecham Laboratoires | Nouveaux agents anti-arythmiques, leur procédé de préparation et compositions pharmaceutiques les contenant. |
WO1997029092A1 (en) * | 1996-02-09 | 1997-08-14 | James Black Foundation Limited | Histamine h3 receptor ligands |
WO1997045108A1 (en) | 1996-05-30 | 1997-12-04 | Children's Hospital Medical Center | Guanidino derivatives as inhibitors of the cytotoxic effect of peroxynitrite |
-
1998
- 1998-02-19 GB GBGB9803536.3A patent/GB9803536D0/en not_active Ceased
-
1999
- 1999-02-15 AU AU25354/99A patent/AU747804B2/en not_active Ceased
- 1999-02-15 AT AT99905049T patent/ATE257473T1/de not_active IP Right Cessation
- 1999-02-15 WO PCT/GB1999/000464 patent/WO1999042458A1/en active IP Right Grant
- 1999-02-15 BR BR9908074-5A patent/BR9908074A/pt not_active IP Right Cessation
- 1999-02-15 RU RU2000124100/04A patent/RU2214406C2/ru not_active IP Right Cessation
- 1999-02-15 US US09/622,544 patent/US6878736B1/en not_active Expired - Fee Related
- 1999-02-15 NZ NZ506720A patent/NZ506720A/en unknown
- 1999-02-15 ES ES99905049T patent/ES2213353T3/es not_active Expired - Lifetime
- 1999-02-15 DE DE69914062T patent/DE69914062T2/de not_active Expired - Fee Related
- 1999-02-15 JP JP2000532410A patent/JP2002504483A/ja active Pending
- 1999-02-15 CN CNB998049328A patent/CN1178927C/zh not_active Expired - Fee Related
- 1999-02-15 EP EP99905049A patent/EP1056733B1/en not_active Expired - Lifetime
- 1999-02-15 CA CA002318836A patent/CA2318836A1/en not_active Abandoned
- 1999-02-19 ZA ZA9901356A patent/ZA991356B/xx unknown
-
2000
- 2000-08-02 NO NO20003918A patent/NO323966B1/no unknown
Also Published As
Publication number | Publication date |
---|---|
JP2002504483A (ja) | 2002-02-12 |
DE69914062T2 (de) | 2004-10-14 |
CN1178927C (zh) | 2004-12-08 |
NO20003918L (no) | 2000-10-03 |
AU747804B2 (en) | 2002-05-23 |
NZ506720A (en) | 2002-03-28 |
EP1056733A1 (en) | 2000-12-06 |
WO1999042458A1 (en) | 1999-08-26 |
RU2214406C2 (ru) | 2003-10-20 |
CA2318836A1 (en) | 1999-08-26 |
ES2213353T3 (es) | 2004-08-16 |
CN1296478A (zh) | 2001-05-23 |
ATE257473T1 (de) | 2004-01-15 |
ZA991356B (en) | 2000-08-21 |
DE69914062D1 (de) | 2004-02-12 |
EP1056733B1 (en) | 2004-01-07 |
BR9908074A (pt) | 2000-10-24 |
GB9803536D0 (en) | 1998-04-15 |
AU2535499A (en) | 1999-09-06 |
US6878736B1 (en) | 2005-04-12 |
NO323966B1 (no) | 2007-07-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE257473T1 (de) | Histamin h3 rezeptor liganden | |
NO20001816L (no) | Substituerte, kondenserte heterosykliske forbindelser | |
ATE264295T1 (de) | 7-substituierte kondensierte ring-tetrazyclin- verbindungen | |
EP1081142A3 (en) | Novel N-Aminoalkylfluorenecarboxamides; a new class of dopamine receptor subtype specific ligands | |
WO2001087845A3 (en) | N-containing heterocyclic compounds and their use as 5-ht antagonists | |
ATE217623T1 (de) | Azindolethylaminderivate als nikotin-acetylcholin-rezeptor bindung verbindungen | |
ES2176311T3 (es) | Nuevos derivados imidazol y procedimiento para su preparacion. | |
FI935887A (fi) | Tiatzolidiinidionijohdannaiset, niiden valmistus ja käyttö | |
DK0868182T3 (da) | Fremgangsmåde til fremstilling af piperidinderivater | |
EA200100310A1 (ru) | Кислородсодержащие гетероциклические соединения | |
TR199500954A1 (tr) | Yeni pirokarbazoller. | |
ES2078356T3 (es) | Derivados de la pirrolidina y de la piperidina. | |
KR920012023A (ko) | 아릴피롤 화합물의 제조방법 | |
GB9812211D0 (en) | Cinnamoyl distamycin analogous derivatives,process for their preparation,and their use as antitumor agents | |
EA200101050A1 (ru) | Замещенные бензолактамные соединения | |
DE69526332D1 (de) | Indol-derivate | |
DK0479175T3 (da) | Pradimicinderivater | |
SE7910387L (sv) | 7alfa-metoxicefalosporinderivat och forfarande for framstellning derav | |
DE60103732D1 (de) | Pyrimidinderivate mit antitumor-wirkung | |
CA2245926A1 (en) | 7-phenyl-1,4-diazepane compounds, process for their preparation, and pharmaceutical compositions containing them | |
EP0806422A3 (en) | Anti-cataract agent | |
YU2397A (en) | 2-phenyl-3-aroylbenzothiophenes using for medicaments obtaining |